e-learning
resources
ERJ
2004
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation
Buhling F., Waldburg N., Reisenauer A., Heimburg A., Golpon H., Welte T.
Source:
Eur Respir J 2004; 23: 620-628
Journal Issue:
April
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Buhling F., Waldburg N., Reisenauer A., Heimburg A., Golpon H., Welte T.. Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation. Eur Respir J 2004; 23: 620-628
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Risk factors associated with the development of interstitial lung abnormalities
Surfactant protein expression at various COPD Gold stages
Dexamethasone inhibits secretory and cytosolic phospholipases A2 in alveolar macrophages in acute lung injury
Related content which might interest you:
SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition
Source: Eur Respir J 2011; 37: 1083-1090
Year: 2011
Cathepsins in bleomycin-induced lung injury in rat
Source: Eur Respir J 2003; 22: 427-435
Year: 2003
Dipeptidyl peptidase I (DPPI) cleaves surfactant protein D (SP-D): A mechanism for immune compromise in the lung
Source: International Congress 2016 – Molecular immunology of the lung
Year: 2016
The proteasome - an intracellular protease that is dysregulated in lung diseases
Source: International Congress 2018 – Proteases: at the cutting edge of lung disease
Year: 2018
The role of matrix metalloproteinases in cystic fibrosis lung disease
Source: Eur Respir J 2011; 38: 721-727
Year: 2011
Mechanisms of emphysema in alpha1-antitrypsin deficiency: molecular and cellular insights
Source: Eur Respir J 2009; 33: 475-488
Year: 2009
Inhibition of airway proteases in cystic fibrosis lung disease
Source: Eur Respir J 2008; 32: 783-795
Year: 2008
Localizing the proteolytic activity: lysosomal and extracellular Cystein cathepsins
Source: ERS Research Seminar 2015
Year: 2015
Type II transmembrane serine protease matriptase is a mediator of pulmonary fibrosis
Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung
Year: 2013
Loss of structural integrity and function of surfactant protein D (SP-D) by cystic fibrosis- related proteases
Source: Eur Respir J 2001; 18: Suppl. 33, 537s
Year: 2001
The role of cathepsin S in lung disease
Source: International Congress 2018 – Proteases: at the cutting edge of lung disease
Year: 2018
Decreased levels of secretory leucoprotease inhibitor in the
pseudomonas
-infected cystic fibrosis lung are due to neutrophil elastase degradation
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009
Development of secretory leukocyte protease inhibitor (SLPI) variants resistant to degradation by neutrophil elastase
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014
A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection
Source: Lung Science Conference 2015
Year: 2015
LSC Abstract – A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
Potential role of cathepsin S in bleomycin-induced lung fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 729s
Year: 2005
Alpha-1 antitrypsin genotypes and associated inhibitory activity towards neutrophil serine proteinases, in vivo
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
Emerging roles of human cysteine proteases in fibrosis and infection
Source: ERS Research Seminar 2015
Year: 2015
Clinical status and activity of lysosomal carboxypeptidase A and cathepsin D in mixed saliva of cystic fibrosis patients
Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health
Year: 2008
Decreased levels of elafin in the lungs of patients with acute lung injury as a result of proteolytic cleavage by the proteasome
Source: Annual Congress 2012 - Mechanistic studies in airway cell biology
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept